ACS Journal Cancer shared a post on X:
“This commentary by Rahul Thakur and Eunice Wang of Roswell Park highlights key advances for acute myeloid leukemia in 2024, including novel cancer drug approvals and other advances supporting the Precision Medicine paradigm shift for AML therapy. ”
“Top advances of the year: Acute myeloid leukemia”
Authors: Rahul K. Thakur, Eunice S. Wang
